✦ LIBER ✦

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer

✍ Scribed by Siqing Fu; Bryan T. Hennessy; Chaan S. Ng; Zhenlin Ju; Kevin R. Coombes; Judith K. Wolf; Anil K. Sood; Charles F. Levenback; Robert L. Coleman; John J. Kavanagh; David M. Gershenson; Maurie Markman; Kristine Dice; Adrienne Howard; Jane Li; Yang Li; Katherine Stemke-Hale; Mary Dyer; Edward Atkinson; Ed Jackson; Vikas Kundra; Razelle Kurzrock; Robert C. Bast Jr.; Gordon B. Mills

Book ID: 113964142
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 645 KB
Volume: 126
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.04.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine Combined with Oxaliplatin (G

Gemcitabine Combined with Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Patients with Advanced Ovarian Cancer Refractory or Resistant to Platinum and Taxane

✍ Raspagliesi, Francesco; Zanaboni, Flavia; Vecchione, Francesca; Hanozet, Frances 📂 Article 📅 2004 🏛 S. Karger AG 🌐 English ⚖ 101 KB

A phase II trial of weekly docetaxel in

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II trial of imatinib mesylate in p

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers

✍ Robert L. Coleman; Russell R. Broaddus; Diane C. Bodurka; Judith K. Wolf; Thomas 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A Phase II trial of oral capecitabine in

A Phase II trial of oral capecitabine in patients with platinum – and taxane – refractory ovarian, fallopian tube, or peritoneal cancer

✍ Judith K. Wolf; Diane C. Bodurka; Claire Verschraegen; Charlotte C. Sun; Donna B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Phase 1b-2a study to reverse platinum re

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

✍ Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Phase 2 study of canfosfamide in combina

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

✍ John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Mo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 404 KB